-+ 0.00%
-+ 0.00%
-+ 0.00%

Rhelion unit Filament Health signs PEX010 psilocybin supply deal with CHDR

PUBT·09/17/2026 11:53:29
Listen to the news
Rhelion unit Filament Health signs PEX010 psilocybin supply deal with CHDR
  • Rhelion unit Filament Health signed a supply and licensing agreement with CHDR to provide PEX010 psilocybin for a low- and medium-dose study.
  • Filament will supply 1 mg and 5 mg PEX010 capsules, including matching placebo, for a CHDR-sponsored trial in Leiden, Netherlands.
  • Agreement adds another research program for PEX010, Filament’s GMP botanical psilocybin candidate already supplied to more than 80 studies.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Rhelion Life Sciences Corp. published the original content used to generate this news brief via Newsfile (Ref. ID: 202609170752NEWSFILECNPR____20260917_314769_1) on September 17, 2026, and is solely responsible for the information contained therein.